Industry News
Stay informed with the latest developments shaping the world of workplace benefits and healthcare access. Our Industry News section curates articles, reports, and media coverage from trusted sources across Canada and beyond.
Private Market Policy Summit Report 2025: Collaboration. Clarity. A Call to Action.
The 2025 Summit brought together insurers, advisors, manufacturers, pharmacists, and patient advocates to discuss the future of Canada’s dual drug coverage model. With over 27 million Canadians relying on private
Access and Affordability: Building Fiscally Responsible Pharmacare Systems
A new C.D. Howe Institute Report concludes that Canada’s best path to pharmacare is through targeted reforms—closing coverage gaps while preserving the mixed public-private model. With most Canadians already insured,
Sounding Board: What plan sponsors should know about pharmacare
Plan sponsors worried about the expense and sustainability of their drug plan might initially embrace a pharmacare plan, hoping to shift drug costs to a new program funded by provincial
Coverage for high-cost, specialty drugs missing from rollout of feds’ pharmacare plan: experts
While the concept behind the federal government’s universal pharmacare plan is well intentioned, the program would make a larger impact for employers by focusing on high-cost and specialty drugs, says
Experts question if Canada’s pharmacare plan is the best approach for all Canadians
Industry leaders say a targeted approach to fill pharmaceutical coverage gaps would be more efficient than spending billions to provide coverage to everyone.
Stakeholders forming coalition to minimize impact of pharmacare on employer-sponsored benefits plans
Several stakeholders from the benefits sector are partnering to form the Smart Health Benefits Coalition, an advocacy group that aims to strengthen the health-care system and address longstanding gaps in
New Coalition Advocates For Comprehensive Healthcare Solutions
OTTAWA, ON, Feb. 21, 2024 /CNW/ – As the deadline for a pharmacare framework between the Liberal government and the NDP nears, the Smart Health Benefits Coalition (SHBC) – a
In strengthening Canada’s health care, we must maintain employer-sponsored drug plans
Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to new drugs, and higher costs for